SIMAP

A pilot project to evaluate a surveillance network to collect information on safety, efficacy and cost/effectiveness of High dose Sublingual Immunotherapy in allergic patients (SIMAP) (Progetto pilota per valutare la sicurezza, l’efficacia e i costi dell’Immunoterapia sublinguale ad alte dosi nei pazienti allergici)